Health & Wellness Today New York
SEE OTHER BRANDS

Get your fresh news on health and wellness in New York

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on May 1, 2025

Newfield Law Group Secures Long Term Disability Benefits for Physician and Former Police Officer

Newfield Law Group Secures Long Term Disability Benefits for Physician and Former Police Officer

Newfield Law Group's Successful Cases Illustrate the Value of an Attorney Preparing the Initial Claim MELVILLE, NY, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- Nationally recognized long term disability insurance attorney Jason Newfield recently …

New HHS Trans Report Counters Medical Care Consensus

New HHS Trans Report Counters Medical Care Consensus

New Federal Report on Transgender Youth Care Advises Against Medical Care for Highly Suicidal Population NEW YORK, NY, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- Today the U.S. Department of Health and Human Services released a report attempting …

Excelsior University Renews National Nurses Week Partnership with CDPHP

Excelsior University Renews National Nurses Week Partnership with CDPHP

Support from CDPHP will fund Excelsior nursing scholarships; CDPHP will also partner on an Excelsior panel discussion on mental health in the nursing field. ALBANY, NY, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- Excelsior University is partnering …

eVero Partners with the National Center for START Services® (NCSS) for Key Database Integration

eVero Partners with the National Center for START Services® (NCSS) for Key Database Integration

eVero’s digitalAGENCY EHR platform is now linked with the START Information Reporting System (SIRS) MELVILLE, NY, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- eVero Corporation (“eVero’), a leading software solution provider for the Home and …

The Brookbush Institute Publishes NEW Course and Glossary Updates: 'Planes of Motion'

The Brookbush Institute Publishes NEW Course and Glossary Updates: 'Planes of Motion'

The Brookbush Institute continues to enhance education with new courses, a modern glossary, an AI Tutor, and a client program generator. NEW YORK, NY, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- Excerpt from the glossary term: Planes of Motion - …

Jennifer A. Beckage Named to Cybersecurity Docket’s 2025 Incident Response 50 for Eighth Consecutive Year

Jennifer A. Beckage Named to Cybersecurity Docket’s 2025 Incident Response 50 for Eighth Consecutive Year

Jennifer A. Beckage of The Beckage Firm named to Cybersecurity Docket’s Incident Response 50, marking her 8th year among top U.S. data breach response lawyers. BUFFALO, NY, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- Jennifer A. Beckage, Esq., CIPP …

Provider Passport Streamlines Provider Management to Save Time, Increase Revenue, and Boost Efficiency

Provider Passport Streamlines Provider Management to Save Time, Increase Revenue, and Boost Efficiency

The unified platform streamlines enrollment, credentialing, privileging, and provider data management to accelerate onboarding and revenue NEW YORK CITY, NY, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- Provider Passport is a unified platform that …

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

WINNIPEG, Manitoba, May 01, 2025 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced a maximum three-year agreement with a value of approximately $65 million to supply the Ontario Ministry of Health with NARCAN® Nasal Spray for the …

Coherus to Participate in Upcoming Investor Conferences

Coherus to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that the company will be webcasting its participation in the upcoming conferences: Citizens Life Science Conference in New York, NY …

Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules

Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules

FREEHOLD, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today advises that, as previously disclosed in …

Premier Health Announces Results of Shareholders’ Meeting

Premier Health Announces Results of Shareholders’ Meeting

MONTRÉAL, May 01, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a leading Canadian Healthtech company, announces that all matters submitted to shareholders for approval were approved at its …

Precipio Announces Q1-2025 Shareholder Update Call

Precipio Announces Q1-2025 Shareholder Update Call

NEW HAVEN, Conn., May 01, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q1-2025 corporate update call on May 15th, 2025 at 5:00 PM ET. The call will include updates on all of the company’s …

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor …

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

DEER PARK, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will …

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

WILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician- …

MacroGenics to Participate in Upcoming Investor Conference

MacroGenics to Participate in Upcoming Investor Conference

ROCKVILLE, MD, May 01, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today …

Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

CARLSBAD, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC …

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights

Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights

– Company advances SL-325 program with an IND filing expected in the third quarter of 2025 – – Cash balance of approximately $60.9 million as of March 31, 2025, expected to fund operations into 2027 – AUSTIN, TX and DURHAM, NC, May 01, 2025 (GLOBE NEWSWIRE …

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FLORHAM PARK, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …

Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy

Cytokinetics Announces New PDUFA Date for Aficamten in Obstructive Hypertrophic Cardiomyopathy

SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) action date for the New Drug …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service